Academic Journal
Q1Dermatology and Therapy
About Dermatology and Therapy
Dermatology and Therapy is a scholarly journal published by its listed publisher. SCImago 2025 lists it in Q1, with an SJR of 1.595 and H-index of 62.
Coverage: 2011-2026. Research categories: Dermatology (Q1).
Verified field sources
- Journal Impact Factor: 4.6 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Psoriasis: Treatment and Pathogenesis; Dermatology and Skin Diseases; Spondyloarthritis Studies and Treatments; Acne and Rosacea Treatments and Effects; Dermatologic Treatments and Research; Skin Protection and Aging.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Systemic Retinoids in Cutaneous T-Cell Lymphoma: A Scoping Review of Clinical Use and Evidence Gaps
Toan Bui, Keon Niknejad, Nicholas Urbanski, Derya Goksu Fidan et al.
2026-10-03 · DOI: 10.1007/s13555-026-01926-4Lifestyle-Driven Phenotypes in Sensitive Skin: A Cross-Sectional, Multicenter Study Across Urbanization Tiers
Jade Conway, Irina Berlin, Céline Blanché, Mathieu Grivet-Seyve et al.
2026-10-03 · DOI: 10.1007/s13555-026-01946-0Tralokinumab Versus Dupilumab for the Treatment of Atopic Dermatitis with Moderate-to-Severe Hand Involvement: A Matching-Adjusted Indirect Comparison
April Armstrong, Leon Kircik, Andrei Metelitsa, Richard B. Warren et al.
2026-10-02 · DOI: 10.1007/s13555-026-01922-8Monitoring the Response to JAK Inhibitor Treatment in Alopecia Areata Using Reflectance Confocal Microscopy and Videotrichoscopy: A 60-Week Observational Study
Kinga Kołcz, Jagienka Włodyka, Adam Reich
2026-10-02 · DOI: 10.1007/s13555-026-01928-2Comparative Pharmacologic Characterization of Povorcitinib (INCB054707) as a Highly Selective Oral JAK1 Inhibitor
Brittney Wass, Aidan M. Fenix, Nina Zolotarjova, Alex Margulis et al.
2026-10-02 · DOI: 10.1007/s13555-026-01910-yEfficacy of Apremilast in Patients with Psoriasis with Limited Skin Involvement, Including High-Impact Site Involvement: A Pooled Analysis of Six Trials
Bruce Strober, Mark Lebwohl, Peter van de Kerkhof, Linda Stein Gold et al.
2026-10-02 · DOI: 10.1007/s13555-026-01921-9D-CARE (Delgocitinib-Chronic hAnd Eczema Response Evaluation): A Retrospective, Multicenter, Real-World Study of Patients with Chronic Hand Eczema (CHE) Treated with Delgocitinib 2% Cream—Temporal Analysis of Symptom and Clinical Sign Response
Maddalena Napolitano, Martina Turco, Luca Potestio, Paolo Romita et al.
2026-10-02 · DOI: 10.1007/s13555-026-01929-1Baricitinib Efficacy Through 4 Years in Responders and Safety up to 5 Years in Adults with Severe Alopecia Areata: Final Results from BRAVE-AA1 and BRAVE-AA2
Ruth Ann Vleugels, Bianca Maria Piraccini, Natasha Mesinkovska, Arash Mostaghimi et al.
2026-10-02 · DOI: 10.1007/s13555-026-01886-9AI-Assisted Quantitative Reflectance Confocal Microscopy Reveals Modulation of Senescence-Associated Epidermal Morphometric Features by a Topical TGF-β Mimetic, XEP™-716 Miniprotein™
Hanane Chajra, Nicolas Rayroux, Corinne Granger, Lionel Breton et al.
2026-10-01 · DOI: 10.1007/s13555-026-01945-1Patterns of Clinical Response in Rollover Adolescent Patients with Alopecia Areata Treated with Ritlecitinib in the Ongoing Long-Term, Open-Label, Phase 3 ALLEGRO-LT Study
Ulrike Blume-Peytavi, Brittany Craiglow, Ilka Arun Netravali, Isabella Doche et al.
2026-10-01 · DOI: 10.1007/s13555-026-01911-xInternational Validation of the Short Version of the Quality of Life Relevance-Acne Questionnaire
Pavel V. Chernyshov, Nives Pustišek, Dimitra Koumaki, Tetiana Pochynok et al.
2026-10-01 · DOI: 10.1007/s13555-026-01941-5Window of Opportunity and Predictors of Sustained Remission in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A 540-Patient Cohort Study
Eva Vilarrasa, Patricia Garbayo-Salmons, Emili Masferrer, Oriol Corral et al.
2026-10-01 · DOI: 10.1007/s13555-026-01900-0Rezpegaldesleukin and Regulatory T Cell Restoration in Immune-Mediated Skin Diseases
João Domingues, Raj Chovatiya, Brett King, Tiago Torres et al.
2026-10-01 · DOI: 10.1007/s13555-026-01936-2Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study
Francesco D’Oria, Costanza Falcidia, Giulio Foggi, Matteo Bianco et al.
2026-10-01 · DOI: 10.1007/s13555-026-01940-6OX40 Ligand/OX40 Axis as the Inflammatory Prequel in Atopic Dermatitis: A Narrative Review
Shawn G. Kwatra, Emma Guttman-Yassky, John Oppenheimer, Bob Geng et al.
2026-10-01 · DOI: 10.1007/s13555-026-01896-7Dermocosmetics for Periocular Aging: Evidence, Mechanisms, and Integration with Aesthetic Procedures. A Narrative Review
Ludmila Prudkin, Jaime Piquero-Casals, Jaime Rengifo-Palacios, Daniela Maleh et al.
2026-09-30 · DOI: 10.1007/s13555-026-01934-4Management Considerations for Patients with Hidradenitis Suppurativa and Lupus Spectrum Disease: A Narrative Review
Claire S. Chung, Kenan Kherallah, Ashley B. Crew, Stratos Christianakis et al.
2026-09-29 · DOI: 10.1007/s13555-026-01930-8Real-World Broadband Light Treatment Strategies and Early Treatment Response in Facial Vascular Lesions: A Retrospective Observational Study
Pinar Dursun, Selen Gezmen, Abdullah Fatih Acik, Gamze Yanpar Erdem et al.
2026-09-26 · DOI: 10.1007/s13555-026-01917-548-Week Real-World Atopic Dermatitis Study on Minimal Disease Activity, Associated Factors, and Agreement Between Clinician- and Patient-Reported Outcomes
Andrea I. Rodriguez-Sanna, Carmen García-Moronta, Julia Castro-Martin, Clara A. Ureña-Paniego et al.
2026-09-25 · DOI: 10.1007/s13555-026-01924-6Supramolecular Salicylic Acid Chemical Peeling Combined with Supramolecular Active Zinc for Malassezia Folliculitis: Efficacy and Safety from a Multicenter, Single-Arm Trial
Yuanzhi Liu, Jinjin Zhang, Wei Lai, Xingdong Ye et al.
2026-09-24 · DOI: 10.1007/s13555-026-01915-7Reviews
Community Reviews
Version History
September 25, 2026 at 7:26 am
September 25, 2026